Accounts Payable, Current of AbbVie Inc. from 31 Dec 2012 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
- Summary
-
AbbVie Inc. quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
- AbbVie Inc. Accounts Payable, Current for the quarter ending 31 Dec 2025 was $3,592,000,000, a 22% increase year-over-year.
- Source SEC data
- View on sec.gov
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)
AbbVie Inc. Quarterly Accounts Payable, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $3,592,000,000 | +$647,000,000 | +22% | 31 Dec 2025 | 10-K | 20 Feb 2026 | 2025 | FY |
| Q4 2024 | $2,945,000,000 | -$743,000,000 | -20% | 31 Dec 2024 | 10-K | 20 Feb 2026 | 2025 | FY |
| Q4 2023 | $3,688,000,000 | +$754,000,000 | +26% | 31 Dec 2023 | 10-K | 14 Feb 2025 | 2024 | FY |
| Q4 2022 | $2,934,000,000 | +$52,000,000 | +1.8% | 31 Dec 2022 | 10-K | 20 Feb 2024 | 2023 | FY |
| Q4 2021 | $2,882,000,000 | +$606,000,000 | +27% | 31 Dec 2021 | 10-K | 17 Feb 2023 | 2022 | FY |
| Q4 2020 | $2,276,000,000 | +$824,000,000 | +57% | 31 Dec 2020 | 10-K | 18 Feb 2022 | 2021 | FY |
| Q4 2019 | $1,452,000,000 | -$94,000,000 | -6.1% | 31 Dec 2019 | 10-K | 19 Feb 2021 | 2020 | FY |
| Q4 2018 | $1,546,000,000 | +$72,000,000 | +4.9% | 31 Dec 2018 | 10-K | 21 Feb 2020 | 2019 | FY |
| Q4 2017 | $1,474,000,000 | +$67,000,000 | +4.8% | 31 Dec 2017 | 10-K | 27 Feb 2019 | 2018 | FY |
| Q4 2016 | $1,407,000,000 | -$190,000,000 | -12% | 31 Dec 2016 | 10-K | 16 Feb 2018 | 2017 | FY |
| Q4 2015 | $1,597,000,000 | +$196,000,000 | +14% | 31 Dec 2015 | 10-K | 17 Feb 2017 | 2016 | FY |
| Q4 2014 | $1,401,000,000 | +$468,000,000 | +50% | 31 Dec 2014 | 10-K | 19 Feb 2016 | 2015 | FY |
| Q4 2013 | $933,000,000 | +$377,000,000 | +68% | 31 Dec 2013 | 10-K | 20 Feb 2015 | 2014 | FY |
| Q4 2012 | $556,000,000 | 31 Dec 2012 | 10-K | 21 Feb 2014 | 2013 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.